v3 Template
C
Cidara Therapeutics
Biotechnology
San Diego, California
Founded
--
Employees
--
Total Funding
$1.2B
Funding Rounds
7
Last Funding
2025-06-26
About Cidara Therapeutics
Cidara Therapeutics is focused on developing targeted immunotherapies to save lives and improve the standard of care for patients facing serious diseases.
Products & Services
Cloudbreak Technology:A platform that creates 'single molecule cocktails' by coupling targeted small molecules and peptides to a human antibody fragment (Fc), resulting in drug-Fc conjugate (DFC) immunotherapies designed to inhibit specific disease targets while engaging the immune system.
Influenza Program:A targeted immunotherapy program under the Cloudbreak platform focusing on influenza.
Specialties
Targeted Immunotherapy
Drug-Fc Conjugate (DFC) Immunotherapies
Influenza Treatment
Immuno-Oncology
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Public Offering T: - FT: Public Offering |
A: 402500000 MR: - FA: $402.5 million FAN: 402500000 |
D: 2025-06-26 FD: 2025-06-26 |
4 investors |
| 2 |
RT: Public Offering T: - FT: Public Offering |
A: 350000000 MR: - FA: $350.0 million FAN: 350000000 |
D: 2025-06-24 FD: 2025-06-24 |
4 investors |
| 3 |
RT: Public Offering T: - FT: Public Offering |
A: 250000000 MR: - FA: $250.0 million FAN: 250000000 |
D: 2025-06-23 FD: 2025-06-23 |
4 investors |
| 4 |
RT: Private Placement T: - FT: Private Placement |
A: 105000000 MR: - FA: $105 million FAN: 105000000 |
D: 2024-11-21 FD: 2024-11-21 |
8 investors |
| 5 |
RT: Milestone Payment T: - FT: Milestone Payment |
A: 11140000 MR: - FA: 11.14 million FAN: 11140000 |
D: 2024-02-12 FD: 2024-02-12 |
1 investors |
| 6 |
RT: Public Offering T: - FT: Public Offering |
A: 19500000 MR: - FA: approximately $19.5 million FAN: 19500000 |
D: 2023-03-07 FD: 2023-03-07 |
1 investors |
| 7 |
RT: Public Offering T: - FT: Public Offering |
A: 17500000 MR: - FA: approximately $17.5 million FAN: 17500000 |
D: 2023-03-03 FD: 2023-03-03 |
1 investors |
Public Offering
Latest
2025-06-26
$402.5M
4 investors (Pro only)
Public Offering
2025-06-24
$350.0M
Public Offering
2025-06-23
$250.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Cidara Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- cidara.com
- Industries
- Biotechnology
- Locations
- San Diego, California
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro